Avid Bioservices Inc (CDMO)

[jakedogman1]

MH, great stuff as usual.... how far down the fda (potential)approval path does bavi (or other drugs) need to be for NCNN players to even consider spending time on them? What is the catalyst for them to consider a bavi? What level of data (preclin or better?) and what level of wow factor? If bavi was a new molecule with minimum testing to date would NCNN consider looking at it? Given the thousands and thousands of molecules out there, what drives this bus?